UNLIMITED FREE ACCESS TO THE WORLD'S BEST IDEAS

close
Already an Engineering360 user? Log in.

This is embarrasing...

An error occurred while processing the form. Please try again in a few minutes.

Customize Your Engineering360 Experience

close
Privacy Policy

This is embarrasing...

An error occurred while processing the form. Please try again in a few minutes.

CLSI POCT05

Performance Metrics for Continuous Interstitial Glucose Monitoring

active, Most Current
Buy Now
Organization: CLSI
Publication Date: 1 November 2020
Status: active
Page Count: 82
scope:

This guideline provides recommendations for methods used to determine analytical and clinical metrics of continuous glucose monitoring (CGM) as an indicator of blood glucose values. It discusses use cases, point accuracy, trend accuracy, evaluation of threshold alerts, system stability and reliability, clinical studies for assessing CGM performance, calibration, traceability of measurement, cybersecurity, and device labeling.

The intended users of this guideline are in vitro diagnostic and medical device manufacturers, regulatory agencies, and health care professionals. This guideline is not intended for use by patients and does not discuss devices that do not meet the definitions of continuous, interstitial, and glucose monitoring.

Document History

CLSI POCT05
November 1, 2020
Performance Metrics for Continuous Interstitial Glucose Monitoring
This guideline provides recommendations for methods used to determine analytical and clinical metrics of continuous glucose monitoring (CGM) as an indicator of blood glucose values. It discusses use...
December 1, 2008
Performance Metrics for Continuous Interstitial Glucose Monitoring; Approved Guideline
This guideline specifies requirements/recommendations for methods for determining analytical and clinical metrics of continuous interstitial glucose monitoring. It defines the following aspects of...

References

Advertisement